Actively Recruiting
Study on Fuzheng Yangxin Prescription for Faster Recovery After Coronary Artery Bypass Surgery in Patients with Qi-Yin Deficiency
Led by Peking University Third Hospital · Updated on 2026-05-08
300
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Ischemic heart disease, caused by narrowing or blockage of coronary arteries, is a leading cause of death worldwide and significantly affects the health of Chinese residents. Coronary artery bypass grafting CABG is considered the gold standard treatment for complex coronary artery disease and is increasingly used, especially in an aging population. Despite its benefits, CABG surgery can cause physical and psychological challenges during early recovery, including complications such as myocardial infarction, heart failure, and atrial fibrillation. This study aims to evaluate the effectiveness and safety of the Fuzheng Yangxin prescription, a traditional Chinese medicine, in improving recovery after CABG in patients with Qi-Yin deficiency syndrome. Participants will be observed in a prospective cohort study to assess the impact of Fuzheng Yangxin prescription compared with placebo on postoperative rehabilitation. The study focuses on patients who have undergone CABG surgery and have a diagnosis of Qi-Yin deficiency after the operation. The research seeks to develop a combined Chinese and Western medicine treatment strategy to enhance recovery, improve quality of life, and reduce complications following cardiac surgery. During the study, researchers will monitor participants health using Seattle Angina Questionnaire SAQ scores at 7 days post-ligation and at 12 months, along with a perioperative safety index at 14 days. These measures will help evaluate the recovery progress and safety of the treatment. The study will also contribute to establishing guidelines for integrated postoperative care and support the wider adoption of combined therapies in cardiac surgery rehabilitation. Total participation duration and follow-up will align with these assessment timepoints.
CONDITIONS
Brief Title
Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting
Research Team
Y
Yichen Gong Doctor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here